Is a complete ICCC research report available?

No complete published report is available for ImmuCell Corporation (ICCC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ImmuCell Corporation (ICCC)

NASDAQ: ICCC · USD

$10.9

-0.20 (-1.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ICCC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	98.9M
Revenue (ttm)	29.9M
Net income (ttm)	-545.4K
EPS (ttm)	-$0.07
Shares out	9M
Volume	19,730
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 29.9M
Net income (ttm): -545.4K
EPS (ttm): -$0.07
Market cap: 98.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ICCC indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000811641
Company name	ImmuCell Corporation
Country	United States
Country code	US
Cusip	452525306
Employees	73
Employees Change	-2%
Employees Change Percent	-2.67
Enterprise value	$104.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1987-04-30
Isin	US4525253062
Last refreshed	2026-07-24
Market cap	$98.9M
Market cap category	Micro-Cap
Price	$10.93
Price currency	USD
Rev Per Employee	410,058.84x
Sector	Healthcare
Sector PE	44.59
Sector PE Fwd	23.48
Sic	2835
Symbol	ICCC
Website	https://immucell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.55%
EV/EBIT	41.92x
EV/EBITDA	20.63x
EV/FCF	31.06x
EV/Sales	3.5x
FCF yield	3.41%
P/B ratio	3.46x
P/S ratio	3.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.35%
EBITDA Margin	16.98%
FCF margin	11.28%
Gross margin	42.59%
Gross Profit	$12.7M
Gross Profit Growth	41.66%
Gross Profit Growth Q	38.86%
Gross Profit Growth3 Y	32.87%
Gross Profit Growth5 Y	15.4%
Net Income	$-545,403
Net Income Growth Q	34.18%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-1.75%
Profit Margin	-1.82%
Profit Per Employee	$-7,471
Profitable Quarters	$1
ROA	4.6
Roa5y	-1.64
ROCE	6.22
ROE	-1.88
Roe5y	-8.21
ROIC	9.23
Roic5y	-3.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.86%
Cagr15y	3.33%
Cagr1y	60.08%
Cagr20y	4.04%
Cagr3y	26.65%
Cagr5y	2.33%
EPS Growth Q	31.25
EPS Growth Quarters	1
EPS Growth Years	2
FCF Growth	327.97%
FCF Growth Q	172.8%
OCF Growth	195.69%
OCF Growth Q	127.03%
OCF Growth10 Y	12.23%
Revenue Growth	9.64x
Revenue Growth Q	28.39x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	23.18x
Revenue Growth5 Y	15.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.67
Assets	$44.1M
Cash	$6.8M
Current Assets	$18.9M
Current Liabilities	$3.9M
Debt	$12.8M
Debt EBITDA	$2.51
Debt Equity	$0.44
Debt FCF	$3.78
Equity	$29.1M
Interest Coverage	5.38
Liabilities	$15M
Long Term Assets	$25.2M
Long Term Liabilities	$11.1M
Net Cash	$-6M
Net Cash By Market Cap	$-6.03
Net Debt EBITDA	$1.17
Net Debt Equity	$0.2
Net Debt FCF	$1.77
Tangible Book Value	$29M
Tangible Book Value Per Share	$3.21
WACC	6.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.82
Inventory Turnover	2.14
Net Working Capital	$9.9M
Quick ratio	2.44
Working Capital	$14.9M
Working Capital Turnover	$2.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.7%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	60.72%
1Y total return	60.03%
200-day SMA	7.35
3Y total return	103.16%
50-day SMA	10.1
50-day SMA vs 200-day SMA	50over200
5Y total return	12.22%
All Time High	13.2
All Time High Change	-17.2%
All Time High Date	2021-01-29
All Time Low	1
All Time Low Change	993%
All Time Low Date	1992-05-01
ATR	0.57
Beta	0.57
Beta1y	1
Beta2y	-0.06
Ch YTD	77.72
High	11.16
High52	12.1
High52 Date	2026-07-14
High52ch	-9.67%
Low	10.9
Low52	4.52
Low52 Date	2025-11-21
Low52ch	141.81%
Ma50ch	8.27%
Price vs 200-day SMA	48.65%
RSI	58.04
RSI Monthly	73.6
RSI Weekly	75.12
Sharpe ratio	1.11x
Sortino ratio	1.81
Total Return	-6.7%
Tr YTD	77.72
Tr15y	63.38%
Tr1m	12.16%
Tr1w	-1.8%
Tr3m	39.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$3.3M
Operating Income Growth Q	76.21
Operating margin	11.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,996,836%
Float Percent	66.29%
Net Borrowing	-1,499,095
Shares Insiders	28.16%
Shares Institutions	19.1%
Shares Out	9,046,799
Shares Qo Q	-1.57%
Shares Yo Y	6.7%
Short Float	0.31%
Short Ratio	0.74
Short Shares	0.21

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$3M
Average Volume	34,683.8x
Bv Per Share	3.22
CAPEX	$-1.1M
Ch10y	60.71
Ch15y	63.38
Ch1m	12.16
Ch1w	-1.8
Ch1y	60.03
Ch20y	120.8
Ch3m	39.77
Ch3y	103.2
Ch5y	12.22
Ch6m	66.62
Change	-1.8%
Change From Open	-0.64
Close	11.13
Days Gap	-1.17
Depreciation Amortization	2,581,928
Dollar Volume	215,648.9
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$2.5M
EBITDA	$5.1M
EPS	$-0.07
F Score	7
FCF	$3.4M
FCF EV Yield	3.22x
FCF Per Share	$0.37
Financing CF	-1,208,734
Fiscal Year End	December
Founded	1,982
Goodwill	95,557
Income Tax	$22,188
Investing CF	-1,052,487
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	7.86
Ma150ch	39.01%
Ma20	10.74
Ma20ch	1.81%
Net CF	2,213,266
Next Earnings Date	2026-08-13
Open	11
Optionable	No
P FCF Ratio	29.29
P OCF Ratio	22.1
Position In Range	11.54
Ppne	25,116,641
Price Date	2026-07-23
Price EBITDA	$19.45
Ptbv Ratio	3.41
Relative Volume	0.57x
Revenue	29,934,295x
SBC By Revenue	1.27x
Share Based Comp	381,605
Tax By Revenue	0.07x
Tr20y	120.81%
Tr6m	66.62%
Us State	Maine
Volume	19,730
Z Score	3.12

ImmuCell Corporation (ICCC)

Coverage state: Market snapshot only — no published research

Generate the first ICCC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ICCC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ICCC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ICCC

Frequently asked questions